课题基金 / 基金详情

Thyroid hormone replacement therapy and the risk of adverse cardiovascular events among individuals with mild subclinical hypothyroidism.

Thyroid hormone replacement therapy and the risk of adverse cardiovascular events among individuals with mild subclinical hypothyroidism.
轻度亚临床甲状腺功能减退症患者的甲状腺激素替代治疗和不良心血管事件的风险。
批准号：
409637
负责人：
Yu Oriana Hoi Yun
金额：
$8.92万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2021-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=409637&lang=en
关键词：
Cardiovascular Disease Levothyroxine Replacement Subclinical Hypothyroidism

项目摘要

项目成果

Yu Oriana Hoi Yun的其他基金

相关文献

中文摘要
翻译
亚临床甲状腺功能减退症是指甲状腺分泌甲状腺激素的能力略低于正常水平。据报道，这种情况影响了5%至10%的人口。通常，有亚临床症状的人
英文摘要
Subclinical hypothyroidism is a condition whereby the function of the thyroid gland is slightly below normal in its ability to produce thyroid hormone. This condition has been reported to affect 5 to 10% of the population. Usually, people with subclinica
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The association between denosumab and the risk of atypical femoral fractures in osteoporosis management
Use of sodium glucose co-transporter-2 inhibitors and the risk of dementia